Dieser Band befa?t sich mit der Entwicklung von RU 486 (Mifapriston), Taxol und 12 anderen, neu entwickelten Medikamenten.

Neben der Beschreibung einzelner Arzneimittel werden auch Anwendungsmoglichkeiten aufgezahlt.

Die Erfinder dieser Medikamente beschreiben daruber hinaus samtliche Schritte von der Entdeckung bis hin zur Einfuhrung im Handel, sowie Probleme, die vor der endgultigen Zulassung der Medikamente bei zustandigen Behorden auftraten.

Daniel Lednicer, PhD, is the author of several books on drug synthesis and discovery. His career in both the private and public sectors has been devoted to the search for new therapeutic agents. Dr. Lednicer spent two decades at the bench as a chemist at the Upjohn Company. Following that, he served as director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. Most recently, he was a project officer at the National Cancer Institute.

Lester A. Mitscher, Ph.D., recognized for his research achievements by numerous institutions, serves as a consultant for the National Institutes of Health, among other organizations. Dr. Mitscher is a professor at the University of Kansas and the Victorian College of Pharmacy at Monash University outside Melbourne, Australia. Victoria Dolby Toews, MPH, a veteran freelance researcher and writer, has written and coauthored many books on health and wellness. She lives in the Pacific Northwest.